Dmitry V. Kravchenko

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · Clinical Infectious Diseases · 2020 · 267 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Highly sensitive field test lateral flow immunodiagnostics of PVX infection

Yu. F. Drygin, A. N. Blintsov, G.M. Grigorenko et al. · Applied Microbiology and Biotechnology · 2011 · 95 citations

Life Sciences, Immunology, Infectious Diseases +11

Multi-component reactions between 2-aminopyrimidine, aldehydes and isonitriles: the use of a nonpolar solvent suppresses formation of multiple products

Vladislav Parchinsky, Olga Shuvalova, O. A. Ushakova et al. · Tetrahedron Letters · 2005 · 78 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors

Angela G. Koryakova, Yan A. Ivanenkov, Elena A. Ryzhova et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

Synthesis of pinacol esters of 1‐alkyl‐1<i>H</i>‐pyrazol‐5‐yl‐ and 1‐alkyl‐1<i>H</i>‐pyrazol‐4‐ylboronic acids

Alexandre V. Ivachtchenko, Dmitry V. Kravchenko, V. I. Zheludeva et al. · Journal of Heterocyclic Chemistry · 2004 · 32 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9